Navigation Links
Nurses as effective as doctors in treatment of HIV patients
Date:8/14/2012

Nurse-centred care of HIV patients can be just as safe and effective as care delivered by doctors and has a number of specific health benefits, according to a new study led by the University of East Anglia (UEA) and the University of Cape Town (UCT).

Published today in The Lancet, the research shows that neither survival rates nor virus suppression reduced when nurses administered antiretroviral drugs to patients in South Africa. Health benefits included: significantly improved detection of tuberculosis; increased white blood cell count; increased weight; and improved adherence with the treatment programme.

More than 15,000 patients took part in the two-year randomised controlled trial in Free State, South Africa. All 31 clinics in the province took part in the study which was conducted by UEA in partnership with UCT and other universities.

South Africa has around six million people infected with HIV more than any other country in the world. Of those patients who would benefit from antiretroviral treatment, less than one in three receive it. In the West, this figure is nearer to 100 per cent.

It is a priority of the World Health Organisation to expand access to antiretroviral treatment, but in South Africa access to the right drugs in limited by a chronic shortage of trained doctors. The South African government is trying to shift healthcare provision from doctors to primary care nurses who are more plentiful. This policy has been resisted by some HIV physicians and nurses, however, who feel administration of these drugs is the proper domain of doctors.

Joint lead author Prof Max Bachmann, of Norwich Medical School at UEA, said: "Our findings show that with very little extra training and support nurses can deliver HIV care that is just as safe and effective as that provided by doctors. Indeed, we found that this model of nurse-centred care had a number of important health benefits.

"There is a critical need to improve access to antiretroviral drugs not only in South Africa but in other low to middle income countries where infection rates are high and doctors are in short supply. HIV programmes worldwide should now consider expanding nurse-centred care, safe in the knowledge that there need not be detrimental effects on patient health or mortality rates if done carefully."

The study is the first to explore 'task-shifting' from doctors to nurses on such a large scale. It ran from 2008 to 2010 and was funded by the UK Medical Research Council, Development Co-operation Ireland, and the Canadian International Development Agency. The project was limited to South Africa, but the findings could have relevance in the West where antiretroviral treatment is usually provided by specialist hospital doctors.

Prof Bachmann and colleagues are currently undertaking further research to explore the cost-effectiveness of task-shifting HIV care from doctors to nurses, as well as strengthening the primary care of other chronic diseases.


'/>"/>

Contact: Simon Dunford
s.dunford@uea.ac.uk
44-160-359-2203
University of East Anglia
Source:Eurekalert

Related medicine news :

1. Phone contact with nurses linked with better outcomes for women with gestational diabetes
2. Nurses need to counteract negative stereotypes of the profession in top YouTube hits
3. Burnt-Out Nurses Linked to More Hospital Infections
4. HIV Prevention Pill Cost-Effective for High-Risk Men: Study
5. Pig stomach mucins are effective as anti-viral agents for consumer products
6. Lower-Dose Radioiodine Effective Against Thyroid Cancer
7. Aspirin as Effective as Warfarin for Heart Failure: Study
8. Mayo Clinic: Exhaustion renders immune cells less effective in cancer treatment
9. Breast cancer effectively treated with chemical found in celery, parsley by MU researchers
10. Researchers make promising discovery in pursuit of effective lymphoma treatments
11. Breast MRI helps predict chemotherapys effectiveness
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... “The Journey: ... faced every danger possible to save lost souls in the Philippines. “The Journey: From ... Carole is a dedicated teacher of the Bible. She has taught all ages and ...
(Date:10/12/2017)... ... October 12, 2017 , ... CitiDent and ... apnea using cutting-edge Oventus O2Vent technology. As many as 18 million Americans ... frequent cessation in breathing. Oral appliances can offer significant relief to about 75 ...
(Date:10/12/2017)... ... 2017 , ... IsoComforter, Inc. ( https://isocomforter.com ), one of the ... new design of the shoulder pad. The shoulder pad provides optimal support and ... pain while using cold therapy. By utilizing ice and water that is circulated from ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... ... drug delivery system that we intend to develop to enable prevention of a ... lead to severe hearing loss, especially in pediatric patients. For cisplatin, hearing loss ...
(Date:10/12/2017)... ... October 12, 2017 , ... Leading pediatric oncology experts at ... D.C., for the 49th Congress of the International Society of Paediatric Oncology ... the Center for Cancer and Blood Disorders at Children’s National, and Stephen ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... -- Diplomat Pharmacy, Inc. (NYSE: DPLO ) ... , and named its founder as Diplomat,s chief information ... Tennessee , will operate under Diplomat subsidiary Envoy ... for health care partners to include IT outsourcing, consulting, ... "In an interoperable world, technology delivers comprehensive insight and ...
(Date:9/28/2017)... , Sept. 28, 2017 Hill-Rom Holdings, ... 2017 earnings conference call and webcast on Friday, November ... a.m. (EDT) and ending at approximately 8:30 a.m. (CDT) ... discussing the company,s 2017 financial performance and guidance for ... opportunities, initiatives to enhance operational performance, and long-range financial ...
(Date:9/25/2017)... R.I. , Sept. 25, 2017  EpiVax, ... assessment, vaccine design, and immune-engineering today announced the ... on the development of personalized therapeutic cancer vaccines. ... has provided exclusive access to enabling technologies to ... Eng., MBA will lead EpiVax Oncology as Chief ...
Breaking Medicine Technology: